comparemela.com

Page 5 - High Tech Equipment News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Xortx stock surges 60% as potential kidney disease drug shows promise in early stage study

Xortx Therapeutics (XRTXF) (XRTX) reported data from a bridging pharmacokinetics trial of its proprietary formulation of oral oxypurinol, Xorlo being explored for kidney disease.The.

Allen davidoffMedicine research laboratoryDiverse team of multiModern medicine research laboratoryDiverse teamMulti ethnic young scientists passes samplesAdvanced labHigh tech equipmentMicrobiology researchers designDevelop drugs

120+ Belarusian developments presented at China International Import Expo

The largest multi-industry exhibition, China International Import Expo, is taking place in Shanghai, and the Belarusian pavilion – High-Tech.

National academy of sciencesBelarusian institute of system analysisChina international import expoEducation ministryBelarusian state universityHigh tech equipmentNational academyState committeeBelarusian stateScience intensive technologiesOptron instrument making plantGreen lineScience rd centreMultifunctional unmannedBelarusian instituteSystem analysis

Relief reports stability data on new formulation of lung disease drug RLF-100

Relief Therapeutics (RLFTF)(RLFTD) reported six-month stability data on a new formulation of potential lung disease therapy RLF-100 (aviptadil).The company said the data showed high.

Raghuram selvarajuMedicine research laboratoryNrx pharmaceuticalsDiverse team of multiModern medicine research laboratoryDiverse teamMulti ethnic young scientists passes samplesAdvanced labHigh tech equipmentMicrobiology researchers designDevelop drugs

Galapagos: Trading At Discount To Cash With A Fast-Growing Marketed Product (NASDAQ:GLPG)

Galapagos has a new CEO since April 2022. The new strategy is taking shape with some research programs scrapped and small assets acquired. Read more here.

Region flamandePaul stoffelsDoing research galapagosMedicine laboratoryDiverse team of multiModern medicine laboratoryDiverse teamMulti ethnic young scientists analysing testAdvanced labHigh tech equipmentMicrobiology researchers designDevelop drugsDoing researchCapital markets dayShares biotechnology

Intercept stock slumps 18% as liver disease drug fails phase 3 trial

Intercept Pharmaceuticals (ICPT) stock fell ~18% on Sept

Medicine research laboratoryIntercept pharmaceuticalsDiverse team of multiModern medicine research laboratoryDiverse teamMulti ethnic young scientists passes samplesAdvanced labHigh tech equipmentMicrobiology researchers designDevelop drugs

vimarsana © 2020. All Rights Reserved.